National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 670433

Case Details

VAERS ID: 670433 (history)  
Form: Version 1.0  
Age: 13.0  
Gender: Female  
Location: Foreign  
   Days after vaccination:0
Submitted: 2016-12-08
   Days after onset:78
Entered: 2016-12-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Other       Purchased by: Unknown
Symptoms: Abasia, Inflammation, Injected limb mobility decreased, Local reaction, Neuropathy peripheral, Pain in extremity, Paralysis, Peripheral swelling, Pyrexia
SMQs:, Cardiac failure (broad), Angioedema (broad), Peripheral neuropathy (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Dystonia (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Extravasation events (injections, infusions and implants) (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? Yes
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Prophylaxis
Preexisting Conditions:
Diagnostic Lab Data:
CDC Split Type: CL0095075131611CHL003145

Write-up: This spontaneous report was received from a 13 years old female patient regarding herself via TV Show. The patient''s medical history and concurrent conditions were not reported. On 21-SEP-2016, the patient was vaccinated with the first dose of GARDASIL intramuscularly in the left arm (vaccinated without the consent of their parents) for prophylaxis (# lot, expiry date, dose unspecified). Concomitant vaccination included DTP vaccine administered in the patient''s right arm on the same day. On the same day (21-SEP-2016), after the vaccination, the patient experienced pain in the arm (not specified which arm), fever, swelling on her right arm persisted, returning repeatedly to the emergency room. The patient was administered with serum, pain medication (unspecified) and treated with many anti-allergic medications including chlorpheniramine, betamethasone without favorable results in the emergency room, and then presented with immobility of the right arm. On 28-OCT-2016 (reported as "on Friday"), the pain in her arm was transferred to the right leg and in the morning, the patient could not walk since her foot was swollen and folded (paralysis right limbs) and the patient was hospitalized from that day. On 02-NOV-2016 (reported as "on Wednesday"), the patient was transferred to another hospital, where she was performed with various tests (unspecified), without obtaining a definitive diagnosis. The evolution of the patient had been unfavorable. According to information provided by the health authority (HA), the patient was assessed by an infectious disease doctor, who diagnosed an inflammatory local reaction in the right arm possibly by the vaccine. The patient was referred to a neurologist to continue the studies, who noted that the diagnosis was a brachial plexus neuropathy. The outcome of the events paralysis right limbs, brachial plexus neuropathy, pain in the arm, right arm swelling was reported as recovered/resolved in approximately 2016. The outcome of the event pyrexia was unknown. The reporter did not provide causality assessment between events and the suspect therapy. No more information was provided. The events brachial plexus neuropathy (Neuralgic amyotrophy), paralysis right limbs (Hemiplegia) were medically significant, had led to hospitalization and disability. The events pain in the arm, right arm swelling and pyrexia were reported as non-serious. The new information was reported by the patient''s parents via a radio station on 28-NOV-2016. The father reported that his daughter was healthy before the vaccination. The symptoms of severe pain and swelling that ended with loss of mobility of the upper limb and hand were reported to have started within minutes of vaccination. The patient''s parents insisted that GARDASIL produced the symptoms. The HA continued to report that the symptoms were more likely to be due to the DTP vaccine, than due to GARDASIL, therefore the DTP vaccine was considered to be a co-suspect vaccination (administered intramuscularly, dose, lot# and expiry date were not reported). Additional information is not expected since no follow up was required or available. This is an amended report, as corrected. For Follow up #1, the Follow-up receipt date should have been entered as 28-NOV-2016. The Follow-up Central Receipt date should have been entered as 29-NOV-2016. Sender''s Comments: MERCK 1611CHL003145:Mfr number.

New Search

Link To This Search Result:

Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166